No photo available


Research Chemistry and Established Synthetic Processes available for Acquisition or Equity investments. These novel molecules have a great potential to be converted into novel drug molecules (antipyretic and/or anti-inflammatory) having good antimicrobial, antifungal and antiviral activities when compared with standard drugs. These activities have been studied using currently available similar drugs in the market.

These molecules are active against bacterial stains like Tuberculosis (Mycobacterium Tuberculosis), B. Subtilis, S. Aureus, E. coli, and Pseudomonas Aeruginosa and plant-based pathogens like, Nigrospora Species, Aspergillus Niger, Botrydepladia Theobroma, Rhizopus Nigricans, Fusarium oxysporum and Mucor mycosis.

These molecules show activities as:

Prostaglandin-E2 synthase 1 inhibitor
HMGCS2 expression enhancer
PfA-M1 aminopeptidase inhibitor
Analgesic (Non-Opioids)
Thiol protease inhibitor
Para Amino Benzoic Acid antagonist.

Further modification of active moiety / functional groups can be supported as needed.

Learn More

Sign up for a free membership. Get instant access to thousands of listings. Learn about our membership plans.

Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum.